Pursuit of Profit Poisons Collaboration

Authors

Jacob S. Sherkow, New York Law SchoolFollow

Document Type

Article

Publication Date

2016

Abstract

The CRISPR–Cas9 patent battle demonstrates how overzealous efforts to commercialize technology can damage science.

Recommended Citation

Nature, vol. 532, pp. 172-173